Cardiac Safety Study in Patients With HER2 + Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2 Positive Breast Cancer|Left Ventricular Function Systolic Dysfunction
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Ado Trastuzumab Emtansine
Sponsor: Medstar Health Research Institute
Collaborators: Genentech, Inc.